Bioelectronics Corp (BIEL)

[4toSchool]

At a guaranteed 216% ROI on a 2-year note, the Whelans are the toxic lenders.

The 216% ROI directly reduces the current shareholder's equity positions.

For example, a current note is due in May, in the approximate amount of $157,000. That note can be converted to about 2.5% of BIEL.

In essence, this noteholder is buying BIEL at a valuation of $6.3 when the market cap is $14 million. So, this noteholder is getting part of the existing shareholder's equity. Investors are getting screwed by "friendly investors".

At this rate, non-insider investors will have the value of their investment diluted to a "nominal" value.